The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor‐infiltrating T cells
Ailin Lepletier(Griffith University), John J. Miles(University of Cambridge), Helen M. McGuire(The University of Sydney), Kimberley Stannard(QIMR Berghofer Medical Research Institute), Corey Smith(QIMR Berghofer Medical Research Institute), Pamela Mukhopadhyay(QIMR Berghofer Medical Research Institute), Viviana P. Lutzky(The University of Queensland), Mark J. Smyth(Peter MacCallum Cancer Centre), Roslyn A. Kemp(University of Otago), Deepak Mittal(QIMR Berghofer Medical Research Institute), Champa N. Ratnatunga(University of Peradeniya), Thomas S. Watkins(QIMR Berghofer Medical Research Institute), William C. Dougall(Queensland University of Technology), Nicola Waddell(QIMR Berghofer Medical Research Institute)
Cited by 38
Related Papers
RANK is essential for osteoclast and lymph node development
|Genes & Development|1999|1.5k
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
|Science Signaling|2016|647